Niagen Bioscience, Inc.
NAGE- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001386570
No open-market purchases or sales by Niagen Bioscience, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $102.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Niagen Bioscience, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 86
- −14 vs. Q2 2021
- Shares held
- 20.5M
- +127.5K (+0.6%) vs. Q2 2021
- Total value
- $129.0M
- −$72.0M (−35.8%) vs. Q2 2021
- New holders
- 6
- 32 more added
- Sold out
- 20
- 25 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $102.1M |
| Q1 2026 | 143 | $162.3M |
| Q4 2025 | 169 | $204.8M |
| Q3 2025 | 162 | $296.1M |
| Q2 2025 | 155 | $417.8M |
| Q1 2025 | 139 | $172.0M |
| Q4 2024 | 123 | $119.3M |
| Q3 2024 | 91 | $64.3M |
| Q2 2024 | 79 | $45.2M |
| Q1 2024 | 67 | $45.7M |
| Q4 2023 | 53 | $16.5M |
| Q3 2023 | 54 | $16.4M |
| Q2 2023 | 55 | $17.7M |
| Q1 2023 | 59 | $18.1M |
| Q4 2022 | 59 | $19.1M |
| Q3 2022 | 62 | $15.0M |
| Q2 2022 | 75 | $25.3M |
| Q1 2022 | 82 | $49.9M |
| Q4 2021 | 83 | $75.9M |
| Q3 2021 | 86 | $129.0M |
| Q2 2021 | 101 | $201.0M |
| Q1 2021 | 96 | $211.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Niagen Bioscience, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,916−100.0% | Sold out |
| Carroll Financial Associates, Inc. | 0 | $0 | 0.00% | −6,605−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −2,950−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −863−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| First Horizon Corp | – | – | – | – | Not filed |